TY - JOUR AU - Colley, D. G. AU - Bustinduy, A. L. AU - Secor, W. E. AU - King, C. H. PY - 2014 DA - 2014// TI - Human schistosomiasis JO - Lancet VL - 384 ID - Colley2014 ER - TY - JOUR AU - Murray, C. J. L. AU - Vos, T. AU - Lozano, R. AU - Naghavi, M. AU - Flaxman, A. D. AU - Michaud, C. AU - Ezzati, M. AU - Shibuya, K. AU - Salomon, J. A. AU - Abdalla, S. AU - Aboyans, V. AU - Abraham, J. AU - Ackerman, I. AU - Aggarwal, R. AU - Ahn, S. Y. AU - Ali, M. K. AU - AlMazroa, M. A. AU - Alvarado, M. AU - Anderson, H. R. AU - Anderson, L. M. AU - Andrews, K. G. AU - Atkinson, C. AU - Baddour, L. M. AU - Bahalim, A. N. AU - Barker-Collo, S. AU - Barrero, L. H. AU - Bartels, D. H. AU - Basáñez, M. -. G. AU - Baxter, A. AU - Bell, M. L. PY - 2012 DA - 2012// TI - Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 JO - Lancet VL - 380 UR - https://doi.org/10.1016/S0140-6736(12)61689-4 DO - 10.1016/S0140-6736(12)61689-4 ID - Murray2012 ER - TY - JOUR AU - Pedrique, B. AU - Strub-Wourgaft, N. AU - Some, C. AU - Olliaro, P. AU - Trouiller, P. AU - Ford, N. AU - Pécoul, B. AU - Bradol, J. -. H. PY - 2013 DA - 2013// TI - The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment JO - Lancet Glob Health VL - 1 UR - https://doi.org/10.1016/S2214-109X(13)70078-0 DO - 10.1016/S2214-109X(13)70078-0 ID - Pedrique2013 ER - TY - JOUR AU - Knopp, S. AU - Becker, S. L. AU - Ingram, K. J. AU - Keiser, J. AU - Utzinger, J. PY - 2013 DA - 2013// TI - Diagnosis and treatment of schistosomiasis in children in the era of intensified control JO - Expert Rev Anti Infect Ther VL - 11 UR - https://doi.org/10.1586/14787210.2013.844066 DO - 10.1586/14787210.2013.844066 ID - Knopp2013 ER - TY - JOUR AU - Panic, G. AU - Duthaler, U. AU - Speich, B. AU - Keiser, J. PY - 2014 DA - 2014// TI - Repurposing drugs for the treatment and control of helminth infections JO - Int J Parasitol Drugs Drug Resist VL - 4 UR - https://doi.org/10.1016/j.ijpddr.2014.07.002 DO - 10.1016/j.ijpddr.2014.07.002 ID - Panic2014 ER - TY - JOUR AU - Dissous, C. AU - Grevelding, C. G. PY - 2011 DA - 2011// TI - Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective? JO - Trends Parasitol VL - 27 UR - https://doi.org/10.1016/j.pt.2010.09.001 DO - 10.1016/j.pt.2010.09.001 ID - Dissous2011 ER - TY - JOUR AU - Beckmann, S. AU - Grevelding, C. G. PY - 2010 DA - 2010// TI - Imatinib has a fatal impact on morphology, pairing stability and survival of adult Schistosoma mansoni in vitro JO - Int J Parasitol VL - 40 UR - https://doi.org/10.1016/j.ijpara.2010.01.007 DO - 10.1016/j.ijpara.2010.01.007 ID - Beckmann2010 ER - TY - JOUR AU - Doerig, C. AU - Grevelding, C. G. PY - 2015 DA - 2015// TI - Targeting kinases in Plasmodium and Schistosoma: same goals, different challenges JO - Biochim Biophys Acta ID - Doerig2015 ER - TY - JOUR AU - Ingram-Sieber, K. AU - Cowan, N. AU - Panic, G. AU - Vargas, M. AU - Mansour, N. R. AU - Bickle, Q. D. AU - Wells, T. N. C. AU - Spangenberg, T. AU - Keiser, J. PY - 2014 DA - 2014// TI - Orally active antischistosomal early leads identified from the open access malaria box JO - PLoS Negl Trop Dis VL - 8 UR - https://doi.org/10.1371/journal.pntd.0002610 DO - 10.1371/journal.pntd.0002610 ID - Ingram-Sieber2014 ER - TY - JOUR AU - Cowan, N. AU - Dätwyler, P. AU - Ernst, B. AU - Wang, C. AU - Vennerstrom, J. L. AU - Spangenberg, T. AU - Keiser, J. PY - 2015 DA - 2015// TI - Activity of N, N’ -diarylurea MMV665852 analogs against Schistosoma mansoni JO - Antimicrob Agents Chemother VL - 59 UR - https://doi.org/10.1128/AAC.04463-14 DO - 10.1128/AAC.04463-14 ID - Cowan2015 ER - TY - JOUR AU - Berriman, M. AU - Haas, B. J. AU - LoVerde, P. T. AU - Wilson, R. A. AU - Dillon, G. P. AU - Cerqueira, G. C. AU - Mashiyama, S. T. AU - Al-Lazikani, B. AU - Andrade, L. F. AU - Ashton, P. D. AU - Aslett, M. A. AU - Bartholomeu, D. C. AU - Blandin, G. AU - Caffrey, C. R. AU - Coghlan, A. AU - Coulson, R. AU - Day, T. A. AU - Delcher, A. AU - DeMarco, R. AU - Djikeng, A. AU - Eyre, T. AU - Gamble, J. A. AU - Ghedin, E. AU - Gu, Y. AU - Hertz-Fowler, C. AU - Hirai, H. AU - Hirai, Y. AU - Houston, R. AU - Ivens, A. AU - Johnston, D. A. PY - 2009 DA - 2009// TI - The genome of the blood fluke Schistosoma mansoni JO - Nature VL - 460 UR - https://doi.org/10.1038/nature08160 DO - 10.1038/nature08160 ID - Berriman2009 ER - TY - JOUR AU - Xiao, S. -. H. AU - Keiser, J. AU - Chollet, J. AU - Utzinger, J. AU - Dong, Y. AU - Endriss, Y. AU - Vennerstrom, J. L. AU - Tanner, M. PY - 2007 DA - 2007// TI - In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species JO - Antimicrob Agents Chemother VL - 51 UR - https://doi.org/10.1128/AAC.01537-06 DO - 10.1128/AAC.01537-06 ID - Xiao2007 ER - TY - JOUR AU - Manneck, T. AU - Haggenmüller, Y. AU - Keiser, J. PY - 2010 DA - 2010// TI - Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni JO - Parasitology VL - 137 UR - https://doi.org/10.1017/S0031182009990965 DO - 10.1017/S0031182009990965 ID - Manneck2010 ER - TY - JOUR AU - Fasano, M. AU - Curry, S. AU - Terreno, E. AU - Galliano, M. AU - Fanali, G. AU - Narciso, P. AU - Notari, S. AU - Ascenzi, P. PY - 2005 DA - 2005// TI - The extraordinary ligand binding properties of human serum albumin JO - IUBMB Life VL - 57 UR - https://doi.org/10.1080/15216540500404093 DO - 10.1080/15216540500404093 ID - Fasano2005 ER - TY - STD TI - European Medicines Agency (EMA): CHMP assessment report for GIOTRIF® (afatinib). [http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002280/WC500152394.pdf] UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/002280/WC500152394.pdf ID - ref15 ER - TY - JOUR AU - Gelmedin, V. AU - Dissous, C. AU - Grevelding, C. G. PY - 2015 DA - 2015// TI - Re-positioning protein-kinase inhibitors against schistosomiasis JO - Future Med Chem VL - 7 UR - https://doi.org/10.4155/fmc.15.31 DO - 10.4155/fmc.15.31 ID - Gelmedin2015 ER - TY - STD TI - WHO: Preventive Chemotherapy in Human Helminthiasis: Coordinated Use of Anthelminthic Drugs in Control Interventions: A Manual for Health Professionals and Programme Managers. 2006. [http://whqlibdoc.who.int/publications/2006/9241547103_eng.pdf] UR - http://whqlibdoc.who.int/publications/2006/9241547103_eng.pdf ID - ref17 ER - TY - STD TI - Calabresi P and Parks RE. Chemotherapy of neoplastic diseases. In: Goodman Gilman A, Goodman LS, Rall TW, Murad F, editors. Goodman and Gilman's. The pharmacological basis of therapeutics, 7th ed. New York: MacMillan; 1985. p. 1240-1307. ID - ref18 ER - TY - JOUR AU - Lee, E. F. AU - Fairlie, W. D. PY - 2015 DA - 2015// TI - Repurposing apoptosis-inducing cancer drugs to treat schistosomiasis JO - Future Med Chem VL - 7 UR - https://doi.org/10.4155/fmc.14.164 DO - 10.4155/fmc.14.164 ID - Lee2015 ER - TY - JOUR AU - Beckmann, S. AU - Long, T. AU - Scheld, C. AU - Geyer, R. AU - Caffrey, C. R. AU - Grevelding, C. G. PY - 2014 DA - 2014// TI - Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib JO - Int J Parasitol Drugs Drug Resist VL - 4 UR - https://doi.org/10.1016/j.ijpddr.2014.07.005 DO - 10.1016/j.ijpddr.2014.07.005 ID - Beckmann2014 ER - TY - STD TI - AstraZeneca: Highlights of prescribing information for CAPRELSA® (vandetanib) tablets. 2011. [http://www1.astrazeneca-us.com/pi/vandetanib.pdf] UR - http://www1.astrazeneca-us.com/pi/vandetanib.pdf ID - ref21 ER - TY - STD TI - Center for drug evaluation and research. Food and Drug Administration: Pharmacology review(s), MEKINIST® (trametinib), Reference ID: 3298856. 2013. [http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/204114Orig1s000PharmR.pdf] UR - http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/204114Orig1s000PharmR.pdf ID - ref22 ER - TY - STD TI - Center for drug evaluation and research. Food and drug administration: Pharmacology review(s), vandetanib, Reference ID: 2923639. 2011. [http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022405orig1s000pharmr.pdf] UR - http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022405orig1s000pharmr.pdf ID - ref23 ER - TY - JOUR AU - Gilmartin, A. G. AU - Bleam, M. R. AU - Groy, A. AU - Moss, K. G. AU - Minthorn, E. A. AU - Kulkarni, S. G. AU - Rominger, C. M. AU - Erskine, S. AU - Fisher, K. E. AU - Yang, J. AU - Zappacosta, F. AU - Annan, R. AU - Sutton, D. AU - Laquerre, S. G. PY - 2011 DA - 2011// TI - GSK1120212 (JTP-74057) is an inhibitor of MEK activity and activation with favorable pharmacokinetic properties for sustained in vivo pathway inhibition JO - Clin Cancer Res Off J Am Assoc Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-2200 DO - 10.1158/1078-0432.CCR-10-2200 ID - Gilmartin2011 ER - TY - JOUR AU - Gustafson, D. L. AU - Bradshaw-Pierce, E. L. AU - Merz, A. L. AU - Zirrolli, J. A. PY - 2006 DA - 2006// TI - Tissue distribution and metabolism of the tyrosine kinase inhibitor ZD6474 (Zactima) in tumor-bearing nude mice following oral dosing JO - J Pharmacol Exp Ther VL - 318 UR - https://doi.org/10.1124/jpet.106.102376 DO - 10.1124/jpet.106.102376 ID - Gustafson2006 ER - TY - STD TI - GlaxoSmithKline: Highlights of prescribing information for MEKINIST® (trametinib) tablets. [http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204114s000lbl.pdf] UR - http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204114s000lbl.pdf ID - ref26 ER - TY - STD TI - AstraZeneca: Summary of product characteristics CAPRELSA®. [http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002315/WC500123555.pdf] UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002315/WC500123555.pdf ID - ref27 ER - TY - JOUR AU - Katz, N. AU - Couto, F. F. B. AU - Araújo, N. PY - 2013 DA - 2013// TI - Imatinib activity on Schistosoma mansoni JO - Mem Inst Oswaldo Cruz VL - 108 UR - https://doi.org/10.1590/0074-0276130207 DO - 10.1590/0074-0276130207 ID - Katz2013 ER -